论文部分内容阅读
美国食品药品监督管理局(FDA)2012年1月5日向公众发出因重大安全问题叫停多利培南(Doribax)临床试验的通知。该试验正在评估Doribax对治疗呼吸机相关性肺炎(VAP)的有效性,试验显示使用Doribax
On January 5, 2012, the U.S. Food and Drug Administration (FDA) issued a public notice of stopping clinical trials of Doribax due to major safety concerns. The trial is evaluating the effectiveness of Doribax in the treatment of ventilator-associated pneumonia (VAP). The trial showed that Doribax